Brief: Avalon Globocare Achieves Major Milestones Advancing Immunotherapeutic Program Towards Combatting Cytokine Storm Associated With Covid-19 Lung Damage And Mortality

Change Agents

20/04/2020 13:35

April 20 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE ACHIEVES MAJOR MILESTONES ADVANCING
IMMUNOTHERAPEUTIC PROGRAM TOWARDS COMBATTING CYTOKINE STORM
ASSOCIATED WITH COVID-19 LUNG DAMAGE AND MORTALITY

Source text for Eikon:  ID:nGNX4xW2zw 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))